Transient diabetes insipidus in a preterm neonate and the challenge of desmopressin dosing

Danielle C M Van der Kaay, Willemijn J M Van Heel, Jeroen Dudink, Erica L T van den Akker

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

BACKGROUND: As neonatal central diabetes insipidus is rare in preterm neonates with intraventricular hemorrhage (IVH), very little is known about dosing and the route of administration of desmopressin treatment.

CASE REPORT: We present a preterm neonate born at 29 weeks' gestation. Within 24 h, she developed bilateral IVH with subsequent post-hemorrhagic hydrocephalus. On the 3rd postnatal day, she developed diabetes insipidus for which she was intranasally administered 0.2 mg desmopressin. This resulted in oliguria with several hours of anuria and a 25-point drop in sodium levels within 15 h.

CONCLUSION: The determination of the desmopressin dose in a preterm neonate is a challenge and there is no consistent literature about the dosing or the route of administration. We suggest starting with a low dose of intranasal desmopressin (0.05-0.1 μg) and titrate in accordance with clinical and laboratory parameters.

Original languageEnglish
Pages (from-to)769-71
Number of pages3
JournalJournal of Pediatric Endocrinology & Metabolism
Volume27
Issue number7-8
DOIs
Publication statusPublished - Jul 2014

Keywords

  • Administration, Intranasal
  • Cerebral Hemorrhage
  • Deamino Arginine Vasopressin
  • Diabetes Insipidus
  • Female
  • Humans
  • Hydrocephalus
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases

Fingerprint

Dive into the research topics of 'Transient diabetes insipidus in a preterm neonate and the challenge of desmopressin dosing'. Together they form a unique fingerprint.

Cite this